| 000 | 01402 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515130301.0 | ||
| 264 | 0 | _c20081211 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAgarwal, Sandeep K | |
| 245 | 0 | 0 |
_aPredictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cSep 2008 |
||
| 300 |
_a1737-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Status |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 | _aWithholding Treatment |
| 700 | 1 | _aGlass, Roberta J | |
| 700 | 1 | _aShadick, Nancy A | |
| 700 | 1 | _aCoblyn, Jonathan S | |
| 700 | 1 | _aAnderson, Ronald J | |
| 700 | 1 | _aMaher, Nancy E | |
| 700 | 1 | _aWeinblatt, Michael E | |
| 700 | 1 | _aSolomon, Daniel H | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 35 _gno. 9 _gp. 1737-44 |
|
| 999 |
_c18114594 _d18114594 |
||